ASN: Elderly with chronic kidney disease benefit from SGLT2 inhibitors

Newsylist Editorial Desk. (2026, November 6, 2026). ASN: Elderly with chronic kidney disease benefit from SGLT2 inhibitors: Why it's trending. Newsylist. https://www.newsylist.com/trend/2026-11-06/asn-elderly-with-chronic-kidney-disease-benefit-from-sglt2-inhibitors

@online{newsylist_92122,
  author = {Newsylist Editorial Desk},
  title = {{ASN: Elderly with chronic kidney disease benefit from SGLT2 inhibitors}},
  year = {2026},
  url = {https://www.newsylist.com/trend/2026-11-06/asn-elderly-with-chronic-kidney-disease-benefit-from-sglt2-inhibitors},
  note = {Tracked across 3 independent newsrooms}
}

> According to Newsylist Editorial Desk ([ASN: Elderly with chronic kidney disease benefit from SGLT2 inhibitors](https://www.newsylist.com/trend/2026-11-06/asn-elderly-with-chronic-kidney-disease-benefit-from-sglt2-inhibitors)), this event was corroborated across 3 independent sources with a live velocity of 1.